Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002596061 | SCV003499837 | likely benign | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV002596061 | SCV005620599 | uncertain significance | not provided | 2024-07-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV005281335 | SCV005943210 | uncertain significance | Inborn genetic diseases | 2025-01-24 | criteria provided, single submitter | clinical testing | The c.6131C>T (p.T2044M) alteration is located in exon 30 (coding exon 29) of the SPTBN2 gene. This alteration results from a C to T substitution at nucleotide position 6131, causing the threonine (T) at amino acid position 2044 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |